previou
report
worker
character
present
middl
east
respiratori
syndrom
mer
sever
acut
respiratori
syndrom
sar
aid
clinic
team
recognit
diagnosi
manag
case
emerg
novel
coronaviru
cov
wuhan
china
tent
name
world
health
organ
similar
clinic
diagnost
manag
guidanc
requir
avail
inform
time
write
indic
viru
spread
beyond
china
infect
confirm
individu
without
direct
contact
index
wuhan
wet
market
huanan
south
china
seafood
market
sale
game
meat
live
anim
also
avail
suggest
humantohuman
transmiss
possibl
like
full
genom
phylogenet
analysi
indic
close
relat
bat
sarslik
cov
fig
compat
zoonot
origin
viru
similar
sarscov
merscov
two
case
confirm
date
thailand
first
old
chines
woman
travel
famili
member
tour
group
develop
symptom
fever
chill
headach
sore
throat
januari
flew
wuhan
directli
thailand
januari
diagnos
isol
report
regular
visit
wet
market
wuhan
index
wet
market
case
report
second
case
confirm
thailand
old
chines
woman
laboratoryconfirm
infect
januari
second
case
link
epidemiolog
first
case
visit
market
wuhan
far
case
recov
well
neg
pressur
isol
facil
bamrasnaradura
institut
thailand
may
discharg
soon
addit
one
case
confirm
male
patient
thirti
japan
stay
wuhan
late
decemb
earli
januari
develop
fever
januari
although
visit
wet
live
anim
market
stay
wuhan
report
close
contact
someon
pneumonia
return
japan
januari
visit
local
clinic
test
neg
influenza
despit
symptom
fever
cough
sore
throat
continu
attend
local
hospit
januari
admit
found
abnorm
infiltr
chest
xray
remain
febril
januari
eventu
test
posit
januari
becam
afebril
day
discharg
home
remain
stabl
second
case
confirm
outsid
china
identifi
two
case
thailand
thu
clinic
symptom
infect
appear
nonspecif
may
similar
influenza
includ
fever
cough
fatigu
sore
throat
runni
nose
headach
short
breath
possibl
ground
glass
shadow
chest
xray
importantli
symptom
appear
persist
longer
case
infect
case
uncompl
influenza
similar
sar
mer
still
specif
licens
antivir
treatment
cov
clinic
manag
mainli
support
infect
control
guidanc
like
base
exist
guidanc
sar
mer
perhap
addit
heighten
precaut
due
larg
unknown
natur
new
viru
also
similar
sar
mer
case
like
lot
variabl
clinic
present
includ
mild
asymptomat
case
may
never
present
healthcar
servic
larger
popul
level
seropreval
studi
test
past
infect
exposur
requir
determin
mani
case
may
exist
whether
superspread
associ
multipl
secondari
infect
occur
promin
sar
also
mer
inde
may
alreadi
featur
epidemiolog
viru
yet
known
pediatr
infect
diagnos
far
infect
vulner
patient
group
transplant
immunocompromis
patient
pregnant
women
chronic
diseas
diabet
liver
kidney
heart
diseas
etc
extrem
bodymass
index
bmi
yet
report
data
await
case
base
current
limit
data
avail
likelihood
mani
milder
asymptomat
case
present
healthcar
servic
earli
compar
casefat
rate
sar
mer
far
two
death
total
case
report
wuhan
oversea
older
patient
variou
comorbid
recent
mathemat
model
studi
imperi
colleg
london
uk
suggest
number
unrecogn
undiagnos
case
could
high
though
may
realist
assum
model
assumpt
reason
accur
situat
evolv
updat
forthcom
sar
first
emerg
infecti
diseas
centuri
came
went
quickli
despit
tremend
global
impact
mer
contrast
remain
larg
confin
middl
east
occasion
export
case
smoulder
sinc
clearli
lot
learn
zoonot
bat
coronavirus
see
fig
hope
scientif
medic
public
health
world
much
better
prepar
time
round
deal
new
emerg
threat
recent
outbreak
unusu
viral
pneumonia
wuhan
citi
china
sicken
dozen
peopl
preliminari
studi
indic
novel
coronaviru
like
caus
outbreak
genet
recombin
shown
contribut
evolut
coronavirus
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
recent
paper
journal
also
describ
involv
recombin
viral
evolut
use
ferret
coronavirus
frcov
exampl
show
recombin
coronavirus
coronavirus
cov
envelop
singl
positivestrand
rna
virus
infect
wide
rang
host
speci
cov
first
report
infect
ferret
associ
epizoot
catarrh
enter
unit
state
refer
ferret
enter
coronaviru
frecv
studi
aim
assess
genet
divers
potenti
role
genet
recombin
evolutionari
dynam
frcov
genet
analys
conduct
five
complet
genom
gene
sequenc
frcov
download
niaid
viru
pathogen
databas
analysi
resourc
sequenc
analys
combin
repres
genom
cov
host
speci
phylogenet
analysi
complet
genom
confirm
divis
four
genet
genera
cov
frcov
fall
alpha
genera
close
relat
cov
mink
fig
frcov
us
japan
ferret
import
us
close
relat
dutch
strain
phylogenet
tree
n
gene
support
two
geograph
depend
lineag
european
american
fig
european
lineag
compris
frcov
netherland
slovenia
american
lineag
compris
frcov
us
japan
phylogenet
tree
rdrp
gene
show
american
japanes
strain
compris
american
lineag
distant
european
lineag
repres
dutch
strain
fig
differ
group
observ
phylogenet
tree
gene
european
lineag
consist
observ
n
tree
howev
american
lineag
divid
two
subgroup
americani
americanii
fig
b
americanii
subgroup
compris
four
frcov
america
close
relat
european
lineag
rather
americani
subgroup
differ
topolog
phylogenet
tree
gene
complet
genom
n
gene
suggest
occurr
potenti
recombin
event
fig
b
simplot
bootscan
analys
five
complet
frcov
genom
perform
investig
genet
variabl
differ
part
genom
potenti
recombin
us
strain
use
queri
compar
four
strain
nl
us
japan
japan
higher
genet
variabl
observ
gene
particularli
termin
end
compar
part
genom
fig
c
averag
share
sequenc
ident
complet
genom
n
gene
rdrp
gene
gene
respect
termin
end
frcov
america
europ
indic
red
blue
box
respect
two
genet
group
identifi
gene
american
frcov
repres
americani
americanii
number
node
indic
bootstrap
support
evalu
replic
recombin
analys
gene
frcov
c
strain
america
use
queri
compar
four
strain
nl
us
japan
japan
c
simplot
show
genet
distanc
queri
sequenc
refer
sequenc
differ
part
genom
bootscan
plot
show
phylogenet
relationship
queri
sequenc
refer
sequenc
differ
part
gene
potenti
region
recombin
event
highlight
dash
line
comparison
put
transcript
regulatori
sequenc
tr
spike
membran
nucleocapsid
gene
five
ferret
coronaviru
frcov
strain
core
tr
indic
bold
access
number
origin
strain
netherland
unit
state
unit
state
japan
japan
fig
next
separ
phylogenet
analys
conduct
recombin
part
nonrecombin
part
gene
phylogeni
recombin
part
show
americanii
subgroup
closer
european
lineag
wherea
phylogeni
nonrecombin
part
show
americani
americanii
subgroup
separ
european
lineag
fig
comparison
put
transcript
regulatori
sequenc
tr
five
strain
show
ident
core
trss
tabl
taken
togeth
result
suggest
potenti
genet
recombin
event
termin
end
gene
frcov
european
american
lineag
howev
due
rel
low
sequenc
ident
gene
small
number
avail
sequenc
possibl
exclud
studi
focus
gene
recombin
could
happen
region
genom
earlier
studi
identifi
recombin
envelop
gene
n
orf
gene
two
japanes
strain
complet
differ
frcov
strain
phylogeni
n
gene
studi
support
observ
phylogeni
rdrp
gene
also
show
two
strain
distant
strain
fig
fig
sequenc
ident
rdrp
gene
two
strain
frcov
rel
low
sourc
two
japanes
strain
clear
potenti
recombin
includ
recombin
cov
could
contribut
uniqu
genom
critic
question
yet
answer
molecular
basi
pathotyp
switch
less
pathogen
frecv
pathogen
frscv
recombin
gene
suggest
associ
transmiss
virul
coronavirus
reason
propos
frscv
may
evolv
frecv
recombin
although
studi
establish
direct
link
detect
recombin
chang
pathogen
interest
see
strain
frscv
includ
msu
wadl
fig
b
futur
vivo
experi
need
clarifi
precis
biolog
implic
recombin
gene
one
major
limit
studi
small
number
frcov
sequenc
avail
public
databas
consid
wide
spread
frcov
extens
use
ferret
anim
model
influenza
pathogen
studi
enhanc
surveil
requir
monitor
spread
genet
divers
frcov
author
declar
conflict
interest
supplementari
materi
associ
articl
found
onlin
version
doi
recent
emerg
african
swine
fever
viru
china
rais
great
concern
journal
coronavirus
larg
famili
virus
caus
respiratori
ill
although
coronavirus
cov
known
decad
rais
great
attent
human
medicin
outbreak
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
sarscov
first
emerg
novemb
guangdong
provinc
southern
china
rapidli
spread
countri
region
infect
individu
death
toll
nearli
ten
year
sar
mer
emerg
caus
human
infect
death
novemb
remain
diseas
global
particularli
middl
eastern
public
health
concern
novel
bat
coronaviru
swine
acut
diarrhea
syndrom
coronaviru
sadscov
caus
death
piglet
rais
concern
coronaviru
decemb
new
coronaviru
similar
sarscov
discov
central
chines
citi
wuhan
case
provinc
diagnos
fig
januari
accord
world
health
organ
http
wwwwhoint
addit
mainland
china
viru
also
detect
japan
thailand
republ
korea
unit
state
travel
wuhan
number
confirm
case
gradual
increas
fig
b
might
partial
due
recent
establish
relev
detect
method
time
could
signal
could
quick
expans
epidem
three
basic
element
requir
infecti
diseas
epidem
sourc
infect
rout
transmiss
suscept
host
human
elimin
sourc
infect
cut
transmiss
rout
usual
effect
mean
block
spread
infecti
diseas
success
preced
emerg
cov
contain
base
elimin
primari
reservoir
sar
bat
suggest
reservoir
host
sarscov
howev
without
intermediari
host
bat
deriv
cov
directli
infect
human
carnivoraintermedi
amplifi
host
civet
sarscov
found
quick
control
intermedi
amplifi
host
ban
wild
anim
trade
key
factor
effect
control
sar
mani
infect
peopl
either
work
frequent
visit
seafood
market
wuhan
apart
fish
market
also
sold
live
wild
anim
spark
concern
viru
might
transmit
anim
human
like
sar
mer
wuhan
cov
cluster
sarssarslik
coronavirus
overal
genom
sequenc
similar
viru
cluster
variou
bat
betacoronaviru
reason
deduc
bat
nativ
host
howev
origin
sourc
remain
unknown
anim
origin
amplifi
host
viru
make
elimin
diseas
sourc
difficult
control
rout
transmiss
anoth
effect
mean
epidem
control
infect
healthcar
worker
famili
cluster
suggest
abil
spread
human
human
although
seafood
market
close
number
confirm
case
continu
gradual
increas
fig
b
support
conclus
viru
spread
humantohuman
contact
previou
research
shown
coronavirus
usual
abil
rapidli
mutat
exclud
possibl
mutat
becom
superspread
seen
sar
frequent
disinfect
peopleintens
place
anim
trade
market
help
stop
spread
viru
unfortun
outbreak
cast
shadow
celebr
lunar
new
year
fall
januari
million
peopl
china
travel
cours
spring
festiv
within
countri
oversea
addit
million
colleg
student
wuhan
million
colleg
student
return
school
winter
vacat
largescal
popul
migrat
could
lead
spread
viru
therefor
possibl
epidem
seriou
spring
festiv
present
nation
health
commiss
china
http
wwwnhcgovcn
list
class
b
infecti
diseas
manag
class
measur
includ
temperatur
monitor
passeng
railway
station
airport
termin
transport
hub
carri
slow
spread
viru
certain
extent
howev
diseas
control
polici
far
enough
strict
method
control
popul
flow
tabl
increasingli
recogn
one
health
approach
humananimalecosystem
interfac
need
effect
investig
prevent
control
emerg
zoonot
diseas
context
emerg
zoonos
human
veterinari
medicin
must
work
togeth
virus
emerg
anim
trade
market
veterinari
worker
need
vigil
concern
whether
virus
potenti
spread
anim
impact
livestock
industri
veterinari
worker
also
activ
invest
epidemiolog
investig
find
natur
host
virus
develop
correspond
detect
method
consid
origin
sourc
like
relat
wild
anim
addit
strict
law
limit
wildlif
market
made
otherwis
emerg
zoonos
wild
anim
occur
near
futur
sever
recent
studi
journal
highlight
threat
pose
mosquitoborn
virus
china
zika
viru
dengu
viru
getah
viru
getv
also
mosquitoborn
viru
classifi
alphaviru
genu
togavirida
famili
genom
getv
linear
positivesens
ssrna
encod
total
nine
viral
protein
c
k
getv
first
isol
culex
mosquito
collect
malaysia
sinc
found
mosquito
asian
countri
surround
pacif
ocean
china
japan
south
korea
mongolia
russia
india
base
viral
isol
andor
molecular
epidemiolog
investig
getv
infect
found
multipl
vertebr
includ
human
monkey
bird
pig
hors
mammal
infect
speci
essenti
mainten
getv
zoonot
transmiss
cycl
natur
howev
getv
long
regard
pathogen
pig
hors
getv
infect
caus
fever
gener
rash
leg
edema
hors
often
associ
fetal
death
reproduct
disord
pig
sever
diseas
outbreak
caus
getv
infect
pig
hors
report
japan
india
china
epidem
statu
getv
becom
increasingli
problemat
recent
pose
great
threat
anim
public
health
initi
getv
detect
sever
new
mosquito
speci
getv
regard
primarili
carri
spread
mosquito
genera
aed
culex
china
getv
first
isol
wild
culex
mosquito
hainan
provinc
recent
detect
andor
isol
mosquito
speci
includ
aedex
vexan
armiger
obturban
armiger
subalbatu
anophel
sinensi
unfortun
mosquito
speci
wide
distribut
china
larg
popul
current
getv
wide
distribut
getv
found
six
provinc
china
howev
number
getvaffect
provinc
dramat
increas
fifteen
fig
addit
mammalian
speci
found
infect
getv
direct
molecular
evid
support
getv
infect
pig
china
first
obtain
taiwan
obtain
five
provinc
mainland
china
fig
addit
hors
infect
getv
china
first
identifi
moreov
getv
infect
fox
cattl
report
northern
china
note
first
time
getv
isol
two
anim
speci
world
undoubtedli
expand
host
rang
viru
furthermor
getv
determin
pathogen
sever
vertebr
speci
neutral
antibodi
getv
identifi
human
sera
china
antibodi
titer
peopl
fever
significantli
higher
healthi
peopl
indic
getv
infect
possibl
associ
diseas
human
getv
infect
pig
hors
china
commonli
associ
piglet
death
fever
respect
getv
infect
could
result
fever
anorexia
depress
neurolog
symptom
even
death
fox
associ
fever
anorexia
depress
cattl
moreov
genet
complex
getv
china
increas
among
publish
getv
strain
major
isol
china
fig
chines
getv
strain
obtain
field
isol
getv
strain
worldwid
classifi
four
group
group
iiv
base
sequenc
gene
fig
nearli
getv
strain
identifi
worldwid
belong
group
iii
except
one
chines
strain
isol
mosquito
one
russian
strain
classifi
group
iv
addit
chines
getv
strain
group
iii
show
special
genet
characterist
exampl
strain
isol
pig
closer
relationship
japanes
getv
strain
chines
getv
strain
strain
isol
mosquito
cluster
togeth
one
mosquitoderiv
chines
getv
strain
show
distant
relationship
six
chines
getv
strain
getv
transmit
individu
mosquito
serv
vector
infect
vertebr
act
amplifi
host
getv
transmiss
cycl
china
vast
territori
wide
varieti
mosquito
vertebr
speci
china
number
newli
discov
vector
infect
vertebr
speci
getv
increas
rapidli
recent
year
howev
threat
pose
getv
yet
attract
enough
attent
china
prevent
control
getv
china
necessari
take
seri
relat
measur
increas
popular
knowledg
getv
decreas
densiti
mosquito
improv
biosafeti
awar
strengthen
epidemiolog
surveil
addit
vaccin
regard
effect
strategi
getv
prevent
control
inact
getv
vaccin
develop
japan
control
spread
viru
hors
http
wwwjpnisseikencojpenproduct
vaccineindexhtml
howev
vaccin
antigen
composit
base
getv
strain
isol
japan
provid
adequ
protect
infect
current
circul
getv
strain
shown
getv
outbreak
japan
therefor
urgent
need
develop
getv
vaccin
use
chines
strain
preval
field
antigen
compon
vaccin
suscept
anim
reduc
increas
threat
getv
anim
public
health
china
none
recent
publish
case
seri
typic
commens
neisseria
spp
diseas
among
eculizumab
recipi
eculizumab
termin
complement
inhibitor
indic
treatment
paroxysm
nocturn
hemoglobinuria
atyp
hemolyt
urem
syndrom
certain
patient
gener
myasthenia
gravi
neuromyel
optica
spectrum
disord
due
complement
inhibit
mani
differ
neisseria
spp
caus
invas
diseas
eculizumab
recipi
eculizumab
recipi
estim
increas
risk
meningococc
diseas
caus
neisseria
meningitidi
eculizumab
recipi
receiv
meningococc
vaccin
prior
therapi
howev
eculizumab
recipi
may
develop
meningococc
diseas
neisseria
infect
despit
vaccin
receipt
patient
receiv
meningococc
vaccin
week
start
eculizumab
us
eculizumab
label
recommend
week
antibiot
prophylaxi
juli
center
diseas
control
prevent
cdc
advis
prescrib
could
consid
antibiot
prophylaxi
eculizumab
recipi
durat
eculizumab
therapi
publish
studi
evalu
efficaci
safeti
antibiot
prophylaxi
eculizumab
recipi
report
potenti
risk
benefit
antibiot
prophylaxi
prevent
meningococc
diseas
case
seri
vaccin
eculizumab
recipi
develop
meningococc
diseas
includ
patient
receiv
eculizumab
within
three
month
preced
diagnosi
meningococc
diseas
defin
report
symptomat
patient
posit
cultur
confirmatori
test
n
meningitidi
bodi
site
faer
case
match
cdc
meningococc
diseas
surveil
data
nation
notifi
diseas
surveil
system
possibl
confirm
infect
serogroup
antibiot
suscept
test
time
onset
tto
calcul
date
first
eculizumab
dose
assum
date
start
antibiot
prophylaxi
date
patient
first
meningococc
diseas
episod
patient
multipl
episod
meningococc
diseas
calcul
describ
perform
use
first
meningococc
diseas
episod
seri
includ
patient
take
antibiot
prophylaxi
time
meningococc
diseas
onset
tabl
four
fatal
due
meningococc
diseas
among
patient
take
prophylaxi
patient
view
express
author
necessarili
repres
impli
endors
us
food
drug
administr
center
diseas
control
prevent
us
govern
serogroup
determin
cdc
multipl
method
slide
agglutin
result
use
final
serogroup
reportedli
receiv
dose
meningococc
vaccin
three
patient
episod
meningococc
diseas
two
patient
take
prophylaxi
one
tto
first
episod
meningococc
diseas
report
patient
take
prophylaxi
take
prophylaxi
median
tto
first
episod
meningococc
diseas
day
prophylaxi
recipi
versu
day
patient
take
prophylaxi
rang
tto
larg
group
day
prophylaxi
recipi
vs
day
nonprophylaxi
recipi
among
patient
suscept
result
avail
penicillin
nonsuscept
report
frequent
patient
take
prophylaxi
isol
patient
take
prophylaxi
isol
limit
data
avail
faer
report
publish
report
possibl
determin
whether
antibiot
prophylaxi
effect
prevent
meningococc
diseas
eculizumab
recipi
howev
descript
analysi
observ
prolong
tto
first
meningococc
diseas
episod
higher
frequenc
reduc
penicillin
suscept
among
prophylaxi
user
compar
nonprophylaxi
user
previous
vaccin
although
result
suggest
antibiot
prophylaxi
may
delay
tto
prescrib
interpret
find
conserv
particularli
given
wide
rang
tto
substanti
differ
patient
age
countri
resid
prophylaxi
recipi
nonprophylaxi
recipi
prescrib
must
weigh
potenti
risk
antibiot
prophylaxi
advers
event
antibiot
resist
potenti
benefit
consid
benefitrisk
balanc
prophylaxi
use
frequent
report
reduc
penicillin
suscept
among
prophylaxi
user
deserv
comment
true
relationship
colon
meningococc
isol
reduc
penicillin
suscept
may
preclud
penicillin
prevent
meningococc
diseas
reduc
penicillin
suscept
could
consequ
select
antibiot
pressur
complic
use
prophylaxi
eculizumab
recipi
also
risk
dissemin
neisseria
gonorrhoea
organ
penicillin
resist
common
analysi
sever
limit
inher
data
sourc
case
deriv
spontan
report
subject
underreport
outcom
bias
report
variabl
qualiti
confound
relationship
antibiot
prophylaxi
tto
possibl
sinc
patient
characterist
includ
age
fig
countri
resid
differ
substanti
group
ascertain
prophylaxi
exposur
challeng
inconsist
prophylaxi
use
could
reduc
differ
tto
group
import
data
defici
includ
miss
inform
meningococc
antimicrobi
suscept
test
result
method
breakpoint
criteria
overal
data
inconclus
howev
observ
trend
toward
prolong
tto
among
prophylaxi
user
also
toward
increas
penicillin
nonsuscept
among
prophylaxi
recipi
valid
potenti
associ
larger
sampl
systemat
ascertain
antibiot
exposur
could
elucid
potenti
impact
prophylaxi
develop
meningococc
diseas
among
eculizumab
recipi
healthcar
profession
remain
vigil
sign
meningococc
diseas
among
eculizumab
recipi
irrespect
prevent
measur
use
author
potenti
conflict
interest
disclos
tabl
characterist
patient
take
antibiot
prophylaxi
patient
take
antibiot
prophylaxi
note
one
patient
prophylaxi
group
year
age
tto
day
one
patient
prophylaxi
group
also
year
age
tto
data
point
overlap
figur
none
read
interest
recent
report
lam
colleagu
journal
compar
global
rate
respiratori
virus
ref
found
respiratori
pathogen
circul
beij
china
influenza
viru
human
rhinoviru
hrv
mycoplasma
mp
major
pathogen
inform
need
consid
clinician
treat
patient
present
influenzalik
ill
ili
influenza
virus
respiratori
virus
bacteria
detect
patient
ili
respiratori
virus
bacteria
includ
season
human
influenza
viru
sflua
human
influenza
viru
b
sflub
human
coronaviru
parainfluenza
viru
piv
adenoviru
adv
enteroviru
ev
hrv
respiratori
syncyti
viru
rsv
boca
viru
bov
human
metapneumoviru
hmpv
chlamydia
cm
mp
well
recogn
patient
infect
pathogen
exhibit
highli
similar
symptom
render
clinic
diagnosi
unreli
limit
aetiolog
epidemiolog
studi
elucid
epidemiolog
characterist
regular
ili
pathogen
great
signific
guid
clinic
diagnos
avoid
abus
antibiot
collect
throat
swab
femal
vs
male
outpati
sought
treatment
outpati
confirm
pathogen
posit
studi
studi
ili
outpati
singl
pathogen
posit
overal
frequent
detect
agent
hrv
byamagata
fig
tabl
short
posit
rate
year
basic
total
po
itiv
rate
top
three
pathogen
mainli
influenza
virus
influenza
pathogen
present
year
studi
howev
influenza
subtyp
persist
domin
strain
rather
mixtur
highintens
peak
singl
subtyp
cocircul
type
subtyp
variabl
intens
occur
fig
consist
ili
surveil
data
demonstr
asynchron
peak
cocircul
differ
pathogen
ili
overal
preval
influenza
rel
low
detect
rate
even
report
studi
conduct
geograph
area
gansu
provinc
china
discrep
influenza
detect
rate
among
patient
ili
differ
area
highlight
geograph
differ
viru
burden
howev
geograph
differ
detect
rate
may
affect
sever
factor
differ
technic
approach
sampl
period
studi
durat
target
popul
global
popul
paediatr
popul
etc
pearson
correl
analysi
perform
consid
number
influenzaposit
case
noninfluenza
case
result
show
former
correl
latter
rs
p
fig
moreov
among
noninfluenza
respiratori
pathogen
hrv
mp
maintain
high
posit
level
rsv
infect
rate
increas
annual
tabl
result
studi
similar
ili
ho
chi
minh
citi
zhuhai
citi
hrv
detect
rate
studi
hrv
great
impact
person
year
old
major
viral
pathogen
ili
studi
period
tabl
mani
region
world
report
outbreak
caus
hrv
uk
vietnam
respect
studi
show
hrv
infect
occur
predominantli
april
juli
august
major
case
year
age
group
tabl
viru
also
highli
associ
influenza
pathogen
respiratori
symptom
caus
hrv
complic
easili
lead
misdiagnosi
delay
treatment
futur
necessari
strengthen
monitor
hrv
ili
patient
provid
data
support
earli
warn
prevent
relev
epidem
situat
avoid
largescal
epidem
studi
also
found
mp
account
larg
proport
pathogen
spectrum
ili
beij
detect
rate
mp
common
pathogen
associ
human
respiratori
infect
caus
endem
even
global
outbreak
among
peopl
age
howev
studi
mp
routin
surveil
home
abroad
inclus
addit
pathogen
ili
studi
might
greatli
increas
posit
detect
frequenc
therefor
earli
epidem
unexplain
fever
necessari
alert
possibl
mp
infect
especi
epidem
occur
close
environ
strength
studi
previou
report
detect
pathogen
especi
mp
cm
ili
patient
influenza
epidem
beij
studi
show
data
studi
peopl
import
refer
data
understand
interact
differ
influenza
subtyp
type
respiratori
pathogen
critic
addit
must
improv
prevent
manag
strategi
ili
result
demonstr
wide
rang
respiratori
pathogen
circul
beij
citi
byamagata
bvictoria
hrv
mp
major
pathogen
recommend
trend
pathogen
spectrum
chang
patient
ili
region
continu
monitor
time
health
depart
also
strengthen
analysi
util
monitor
data
track
activ
level
variat
influenza
viru
rate
address
fever
outbreak
time
manner
none
work
support
chn
beij
chaoyang
district
scienc
technolog
plan
project
grant
nation
major
scienc
technolog
project
control
prevent
major
infecti
diseas
china
funder
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
grate
patient
clinic
laboratori
staff
two
hospit
concern
numer
support
staff
chines
academi
medic
scienc
peke
union
medic
colleg
china
author
declar
compet
interest
read
great
interest
report
evalu
use
apheresi
sever
falciparum
malaria
loiasi
babesiosi
system
review
studi
odedra
et
al
demonstr
suggest
apheresi
may
use
adjunct
treatment
babesiosi
loiasi
addit
uncommon
infecti
diseas
much
concern
efficaci
anoth
modal
polymyxin
b
hemoperfus
pmxhp
reduc
blood
endotoxin
level
sepsi
clinic
outcom
patient
sepsi
septic
shock
therefor
conduct
metaanalysi
investig
clinic
efficaci
pmxhp
mortal
patient
sepsi
septic
shock
literatur
review
use
pubm
databas
eight
random
clinic
studi
compar
use
pmxhp
standard
therapi
mortal
patient
sepsi
septic
shock
identifi
tabl
summar
characterist
includ
eight
random
trial
two
studi
multin
studi
japan
common
countri
studi
site
six
trial
multicent
studi
two
trial
singl
center
studi
addit
nakamura
et
al
studi
studi
initi
pmxhp
first
day
final
durat
use
pmxhp
vari
accord
studi
design
overal
total
patient
enrol
five
hundr
ten
patient
assign
pmxhp
group
standard
therapi
group
respect
receiv
pmxhp
standard
therapi
mortal
rate
respect
signific
differ
observ
two
group
risk
ratio
ci
subgroup
analysi
two
studi
perform
pmxhp
four
hour
per
session
patient
receiv
pmxhp
lower
mortal
rate
standard
therapi
risk
ratio
ci
differ
reach
statist
signific
six
studi
evalu
effect
pmxhp
two
hour
per
secess
also
show
signific
differ
mortal
among
receiv
pmxhp
receiv
therapi
risk
ratio
ci
conclus
base
find
metaanalysi
indic
surviv
benefit
justifi
routin
use
pmxhp
treat
patient
sepsi
septic
shock
none
asfaffect
countri
name
time
first
outbreak
asf
determin
countri
indic
demonstr
total
asf
outbreak
total
anim
loss
countri
russia
geograph
area
within
asia
shown
contagi
hemorrhag
diseas
domest
pig
high
morbid
mortal
howev
current
effect
vaccin
prevent
control
diseas
caus
agent
asf
asf
viru
asfv
describ
isol
first
time
kenya
asfv
endem
countri
subsaharan
africa
sardinia
viru
spread
european
american
countri
recent
spread
asia
asia
except
russia
countri
experienc
asf
outbreak
august
china
report
first
asf
outbreak
one
year
asfv
quickli
spread
provinc
mainland
china
time
submit
manuscript
novemb
total
asf
outbreak
china
record
oie
fig
http
wwwoie
intenanimalhealthintheworldinformationonaquaticandterrestrialanimaldiseasesafricanswinefeverreportsonasf
mongolia
report
first
outbreak
januari
asf
rapidli
spread
nine
asian
countri
next
eight
month
includ
vietnam
februari
cambodia
march
north
korea
may
lao
june
philippin
juli
myanmar
august
russia
august
south
korea
septemb
timorlest
septemb
total
asf
outbreak
affect
anim
report
asia
result
great
econom
loss
fig
moreov
emerg
rapid
spread
asfv
asia
also
pose
threat
unaffect
countri
asf
transmit
directli
contact
sick
healthi
pig
indirectli
untreat
swill
feed
product
asia
rais
larg
number
pig
pork
main
meat
sourc
local
peopl
among
asian
countri
china
respons
half
global
pig
popul
therefor
asia
high
pig
densiti
note
backyard
smallscal
farm
weak
biosecur
system
compris
larg
proport
pig
herd
asian
countri
develop
swine
industri
yet
asfunaffect
asian
countri
indonesia
india
malaysia
asfv
stabl
infecti
long
period
time
blood
fece
tissu
viral
contamin
product
howev
common
feed
pig
untreat
swill
asia
therefor
food
also
potenti
sourc
asf
spread
shortli
first
asf
outbreak
china
asfv
found
dri
pig
blood
use
pig
feed
import
protein
sourc
pig
china
develop
swine
industri
high
pig
densiti
low
biosecur
system
asia
provid
opportun
contact
healthi
pig
asfvaffect
pig
contamin
may
contribut
spread
asf
asia
pastfutur
luggagepork
productswast
aircraftsvesselspasseng
asfaffect
countri
repres
anoth
import
rout
asf
spread
japan
south
korea
report
asfv
detect
pork
product
china
april
august
respect
http
html
develop
global
economi
whole
intern
econom
cooper
exchang
increasingli
frequent
countri
developingdevelop
pig
industri
implement
enhanc
nation
sanitari
measur
monitor
quarantin
inspect
travel
asfaffect
asian
countri
soft
tick
genu
ornithodoro
consid
reservoir
asfv
wide
distribut
asia
sever
asfv
epidemiolog
cycl
involv
tick
identifi
surprisingli
new
asfv
variant
strain
recent
identifi
hard
tick
dermacentor
collect
sheep
bovin
china
expand
vector
host
asfv
wild
boar
also
suscept
asfv
play
import
role
asf
persist
endem
area
sporad
outbreak
restrict
movement
area
wild
boar
regard
sourc
geograph
expans
asf
novemb
asfv
found
dead
wild
boar
border
china
north
korea
although
report
asfv
wild
boar
asia
sinc
consid
wide
geograph
distribut
wild
boar
asfaffect
andunaffect
asian
countri
potenti
role
asf
spread
unaffect
counti
underestim
note
latest
asf
outbreak
asia
occur
timorlest
fig
timorlest
long
geograph
distanc
nearest
asfaffect
asian
countri
philippin
km
closer
australia
km
still
unclear
asfv
spread
countri
howev
asf
outbreak
timorlest
undoubtedli
great
threat
pig
australia
summari
multipl
factor
probabl
respons
rapid
spread
asfv
asia
control
continu
spread
asfv
asia
reduc
potenti
threat
current
unaffect
countri
need
joint
updat
nation
polici
increas
intern
cooper
differ
countri
worldwid
increas
biosafeti
awar
develop
modern
pig
industri
reduc
densiti
backyard
pig
strengthen
biosafeti
manag
travel
luggag
develop
strategi
control
relat
tick
wild
boar
none
recent
hu
colleagu
declar
journal
isol
two
avian
influenza
virus
aiv
deriv
recombin
event
aiv
pose
great
challeng
diseas
control
due
rapid
evolut
viral
genom
compris
eight
negativestrand
rna
segment
lack
proofread
mechan
rna
replic
result
high
frequenc
point
mutat
addit
gener
genet
divers
rapid
mutat
multipl
aiv
strain
coinfect
singl
cell
eight
segment
aiv
genom
reassort
yield
progeni
virion
novel
combin
segment
process
term
reassort
frequent
process
addit
homolog
recombin
import
evolutionari
mechan
drive
format
genet
variat
virus
allow
overcom
select
pressur
adapt
new
environ
host
howev
sinc
aiv
rna
alway
encapsid
ribonucleoprotein
complex
recombin
virus
rare
previous
describ
put
recombin
event
prove
falseposit
signal
thu
two
recombin
event
suggest
hu
et
al
studi
unexpect
examin
potenti
recombin
event
detail
collect
avail
complet
avian
aiv
sequenc
public
ncbi
http
wwwncbinlmnih
gov
gisaid
http
wwwgisaidorg
databas
redund
sequenc
laboratori
strain
remov
final
uniqu
respect
sequenc
use
recombin
analys
number
statist
method
develop
detect
recombin
sequenc
differ
method
distinct
perform
characterist
effici
therefor
perform
recombin
use
program
bootscan
chimaera
genecov
lard
maxchi
rdp
siscan
detect
method
avoid
fals
posit
record
recombin
event
detect
signific
signal
least
three
differ
method
use
approach
detect
three
sequenc
seven
sequenc
strong
signal
recombin
tabl
howev
sequenc
includ
two
virus
suggest
recombin
signal
hu
et
al
determin
whether
strict
criteria
lead
conflict
result
hu
et
al
reanalyz
data
use
hu
et
al
potenti
recombin
signal
simplot
program
use
studi
simplot
graph
hu
et
al
clearli
show
high
degre
similar
within
ha
na
sequenc
fig
b
b
use
bootscan
analys
control
fals
posit
signal
signal
greater
observ
permut
tree
indic
potenti
recombin
event
howev
bootscan
analys
demonstr
signific
signal
recombin
sequenc
fig
c
c
suggest
hu
et
al
use
bootscan
analysi
avoid
detect
fals
posit
signal
thu
reach
incorrect
conclus
aiv
deriv
recombin
examin
variabl
site
sequenc
ha
na
gene
fig
e
f
e
f
suggest
recombin
region
hu
et
al
variabl
site
aiv
high
mutat
rate
random
mutat
caus
fals
posit
signal
conclus
describ
approach
detect
recombin
breakpoint
aiv
show
homolog
recombin
rare
bioinformat
analys
use
detect
presenc
recombin
assess
nonrandom
signal
need
multipl
method
must
use
avoid
fals
posit
result
author
declar
conflict
interest
dear
editor
diagnost
perform
xpert
mtbrif
ultra
xpert
ultra
comparison
xpert
mtbrif
xpert
assay
detect
paediatr
pulmonari
tuberculosi
document
journal
end
tuberculosi
tb
strategi
aim
achiev
reduct
incid
reduct
mortal
obvious
sensit
rapid
access
diagnost
import
factor
overcom
tb
one
oldest
deadliest
diseas
mankind
sputum
smear
microscopi
inexpens
easi
perform
still
primari
method
diagnosi
tb
although
maximum
sensit
found
around
optim
condit
cultiv
antimicrobi
suscept
still
consid
gold
standard
howev
due
lack
access
mycobacteriolog
laboratori
facil
point
care
test
requir
earli
diagnosi
prevent
dissemin
drug
resist
strain
world
xpert
mtbrif
assay
cepheid
sunnyval
ca
usa
commonli
use
pointofcar
assay
tuberculosi
tb
endors
decemb
recommend
expand
use
patient
sinc
end
march
recommend
replac
xpert
ultra
ultra
cepheid
sunnyval
california
advanc
version
better
tb
detect
capabl
definit
identif
rifampicin
resist
especi
import
problemat
case
hiv
coinfect
pediatr
patient
extra
pulmonari
tb
case
increas
sensit
may
predispos
falseposit
result
due
sampl
cross
contamin
particularli
laboratori
heavi
work
load
replac
xpert
mtbrif
assay
ultra
assay
decemb
hospit
local
istanbul
turkey
million
inhabit
live
incid
tuberculosi
per
peopl
turkey
report
process
clinic
materi
patient
smear
microscopi
cultur
xpert
ultra
assay
decemb
specimen
first
digest
nacetyllcystein
sodium
hydroxid
concentr
use
standard
method
smear
microscopi
done
use
ziehlneelsen
auraminerhodamin
stain
ml
resuspend
pellet
inocul
liquid
cultur
use
mycobacteria
growth
indic
tube
mgit
bactec
instrument
bd
microbiolog
system
spark
md
usa
ml
inocul
medium
cultur
posit
growth
acidfast
bacilli
underw
confirm
tuberculosi
complex
antigen
detect
xpert
ultra
assay
done
ad
sampl
reagent
first
collect
sputum
specimen
dilut
ml
result
mixtur
ad
xpert
ultra
cartridg
respiratori
specimen
sputum
brochoalveolar
lavag
deep
tracheal
aspir
gastric
aspir
consist
specimen
specimen
csf
urin
tabl
patient
women
mean
age
year
month
year
age
although
sampl
pcr
posit
could
isol
tuberculosi
sampl
repeat
sampl
exclud
analyz
patient
six
patient
trace
posit
low
posit
bronchoscopi
unit
overal
aliz
posit
result
detect
follow
bronchoscopi
high
posit
patient
patient
smear
neg
clinician
perform
procedur
anxiou
want
know
fals
posit
convinc
wait
result
screen
unit
use
cleantrac
surfac
atp
cleantrac
water
atp
test
usa
also
obtain
sampl
bronchoscop
environ
smear
examin
cultur
unit
autom
wash
machin
use
high
level
disinfect
done
orthophthalaldehyd
opa
atp
level
accept
limit
mycobacteria
detect
sampl
five
patient
remain
cultur
neg
therapi
given
among
cultur
neg
patient
trace
posit
learn
tb
treatment
previous
two
patient
low
level
pcr
positivitiy
bal
sampl
support
clinic
radiolog
find
therefor
receiv
tb
treatment
dorman
et
al
enrol
particip
sputum
sampl
studi
done
ten
refer
laboratori
eight
countri
south
africa
uganda
kenya
india
china
georgia
belaru
brazil
sensit
expert
ultra
particip
smearneg
cultureposit
sputum
particip
posit
xpert
ultra
test
posit
cultur
trace
tuberculosi
identifi
followup
cultur
result
line
studi
show
xpertposit
cultur
neg
result
common
individu
histori
tuberculosi
ultra
provid
categori
defin
trace
exist
xpert
correspond
specimen
posit
pcr
target
multicopi
gene
neg
pcr
target
singl
copi
gene
rpob
posit
trace
result
relat
presenc
low
quantiti
tuberculosi
dna
evalu
care
inconsist
cultur
pcr
result
big
challeng
clinician
fals
posit
result
relat
amplif
dead
bacilli
environment
contamin
previou
tb
treatment
fals
posit
relat
endoscop
procedur
studi
despit
high
level
disinfect
surfac
bronchoscop
remain
posit
mycobacterium
dna
although
number
clinic
sampl
high
everi
patient
count
difficult
time
evalu
result
guid
clinician
arend
et
al
metaphor
speak
defin
xpert
knife
xpert
ultra
sharper
knife
hope
hear
addit
studi
algorithm
assess
xpert
ultra
improv
sensit
solut
avoid
trap
treat
patient
dead
bacilli
far
best
combin
pcr
result
radiolog
clinic
evid
especi
lack
convent
microscopi
cultiv
procedur
